We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...
Our Quality Edge is how we blend Empathy, Reliability and Responsiveness to deliver exceptional service to all our clients.
We Partner with Clients to execute Outcomes Research in emerging markets.
We develop results-driven market access solutions for clients in emerging markets.
We are devoted to strengthening emerging pharmaceutical markets.
Market Access Solutions
Innovative Access Strategies
Our Quality Edge
Roche & Saed Charity hold awareness workshop about multiple sclerosis disease. phrmaccess.com/x/l8 pic.twitter.com/9YIIffsKPH
About 13 hours ago from Carapinha & Company's Twitter
Market Access Landscape in the Middle East. phrmaccess.com/x/la pic.twitter.com/9Ew6zEhcQ8
About 14 hours ago from Carapinha & Company's Twitter
Only five out of 696 hospitals‚ clinics got a ‘pass mark’ in SA. phrmaccess.com/x/lc pic.twitter.com/xZetflCeMz
About 16 hours ago from Carapinha & Company's Twitter
Co-Pay Tactic by Benefit Managers Credited with Cutting Prescription Drug Prices. phrmaccess.com/x/l3 pic.twitter.com/pJbN35VeQo
About 5 days ago from Carapinha & Company's Twitter
Shhh! Many Pharmacists Are Legally Banned From Telling Patients This. phrmaccess.com/x/l6 pic.twitter.com/78dOKPwSVh
RPT-U.S. FDA wants to shorten new drug monopolies to cut costs. phrmaccess.com/x/kz pic.twitter.com/Z5JUOQFt3D
About 6 days ago from Carapinha & Company's Twitter
Big pharma CEO: Congress is not solution oriented. phrmaccess.com/x/l0 pic.twitter.com/azPwscOatN
Get your message out to an international audience. Shout Out Campaign. carapinha.com/contact-us-2/ pic.twitter.com/ya3igcR4dF
Gap in regulating biotech drug copies prompts WHO to step in. phrmaccess.com/x/kh pic.twitter.com/EM0fVQiUcx
Last week from Carapinha & Company's Twitter
Yale Professors Highlight New Trend In Pharma. phrmaccess.com/x/kl pic.twitter.com/FN9fcc1TJL
European Commission Aims to Boost Generic, Biosimilar Manufacturing. phrmaccess.com/x/ke pic.twitter.com/Ift8MW5bb9
About 2 weeks ago from Carapinha & Company's Twitter
Ekurhuleni partners with private pharmacies to reduce waiting times at clinics. phrmaccess.com/x/jo pic.twitter.com/oizwhu3CW5
About 3 weeks ago from Carapinha & Company's Twitter
Chinese money floods US biotech as Beijing chases new cures. phrmaccess.com/x/ja pic.twitter.com/YI5J89aikE
NHS England’s Simon Stevens – no Trump drug price rhetoric here. phrmaccess.com/x/jd pic.twitter.com/2Tr2HrW2Qi
China to reduce cancer drug prices. phrmaccess.com/x/je pic.twitter.com/u2AmADcqNj